tobramycin



tobramycin


SMILES NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O
InChIKey NLVFBUXFDBBNBW-PBSUHMDJSA-N

Chemical Properties

Hydrogen bond acceptors 14
Hydrogen bond donors 10
Rotatable bonds 6
Molecular weight (Da) 467.3


No bioactivity data available.

tobramycin


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV


Compound is not listed as a drug.